Power Law company profile

Generation Bio

Biotech & Life Sciences · Cambridge, United States · Founded 2016 · IPO 2020 Unicorn

Engages in developing genetic medicines through gene therapy platform for intrinsic hepatic diseases and systemic diseases

Revenue

$20M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

10 investors on Generation Bio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Atlas Venture

Series B+ 9 investors entered at this stage

T. Rowe Price

Farallon Capital Management

Transformation Capital

Invus

Foresite Capital

Wellington Management

Fidelity Investments

Casdin Capital

Deerfield

Generation Bio mafia

Startups founded by Generation Bio alumni

Former Generation Bio employees who went on to start their own companies. Sorted by Dealroom signal score.

Dyne TherapeuticsEst. 2017

Phillip SamayoaUnited States

Signal score92

Umoja BiopharmaEst. 2019

ASAndy ScharenbergUnited States

Signal score83

Frontera TherapeuticsEst. 2019

Robert KotinUnited States

Signal score65

Carbon BiosciencesEst. 2021

SASebastian AguirreUnited States

Signal score61

Tortugas NeuroscienceEst. 2024

JJJeffrey JonasUnited States

Signal score55

Book a demo to explore the full alumni network →

Global footprint

Where Generation Bio has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States98.2%

🇮🇳 India1.2%

🇨🇦 Canada1%

3 countries shown

Web traffic by country

3.8K monthly visits
across markets

🇺🇸 United States86.8%

🇮🇳 India13.2%

Top 2 markets shown

Patent intelligence

$11M patent portfolio · 45 active families

Estimated portfolio value

$11M

18.2× smaller than top peer Celularity ($195M)

45 active patent families

Where Generation Bio innovates Cell biologyMolecular biologyNanoparticleCellViral vector

Where Generation Bio concentrates vs peers

Each axis is a top-10 topic across Generation Bio and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Generation Bio

An AI-synthesized read of the highest-engagement posts about Generation Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Generation Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles